Disulfide-rich macrocyclic peptides as templates in drug design.

[1]  Horst Kessler,et al.  The Cyclic Cystine Ladder of Theta‐Defensins as a Stable, Bifunctional Scaffold: A Proof‐of‐Concept Study Using the Integrin‐Binding RGD Motif. , 2014, Chembiochem : a European journal of chemical biology.

[2]  Miriam Góngora-Benítez,et al.  Multifaceted roles of disulfide bonds. Peptides as therapeutics. , 2014, Chemical reviews.

[3]  Mehdi Mobli,et al.  Vicinal disulfide constrained cyclic peptidomimetics: a turn mimetic scaffold targeting the norepinephrine transporter. , 2013, Angewandte Chemie.

[4]  David J. Craik,et al.  Molecular Grafting onto a Stable Framework Yields Novel Cyclic Peptides for the Treatment of Multiple Sclerosis , 2013, ACS chemical biology.

[5]  David J Craik,et al.  Cyclotides as grafting frameworks for protein engineering and drug design applications. , 2013, Biopolymers.

[6]  J. Tam,et al.  Biomimetic synthesis of cyclic peptides using novel thioester surrogates. , 2013, Biopolymers.

[7]  D. Craik,et al.  Design, synthesis, and characterization of cyclic analogues of the iron regulatory peptide hormone hepcidin. , 2013, Biopolymers.

[8]  N. Neamati,et al.  In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. , 2013, Journal of the American Chemical Society.

[9]  D. Craik,et al.  Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism , 2013, PloS one.

[10]  L. Pereira de Almeida,et al.  Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment , 2013, Molecular therapy. Nucleic acids.

[11]  Jennifer A. Getz,et al.  Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration. , 2013, ACS chemical biology.

[12]  D. Craik,et al.  High-affinity Cyclic Peptide Matriptase Inhibitors* , 2013, The Journal of Biological Chemistry.

[13]  K. Woodburn,et al.  Peginesatide Clearance, Distribution, Metabolism, and Excretion in Monkeys following Intravenous Administration , 2013, Drug Metabolism and Disposition.

[14]  Miriam Góngora-Benítez,et al.  Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs. , 2013, Future medicinal chemistry.

[15]  U. Ribel,et al.  Insulin analog with additional disulfide bond has increased stability and preserved activity , 2013, Protein science : a publication of the Protein Society.

[16]  Norelle L Daly,et al.  The Cyclic Cystine Ladder in θ-Defensins Is Important for Structure and Stability, but Not Antibacterial Activity* , 2013, The Journal of Biological Chemistry.

[17]  Asher Mullard.  2012 FDA drug approvals , 2013, Nature Reviews Drug Discovery.

[18]  N. Germain,et al.  Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active , 2013, Peptides.

[19]  H. Kolmar,et al.  Oxidative Folding of Peptides with Cystine‐Knot Architectures: Kinetic Studies and Optimization of Folding Conditions , 2013, Chembiochem : a European journal of chemical biology.

[20]  D. Craik,et al.  The Future of Peptide‐based Drugs , 2013, Chemical biology & drug design.

[21]  J. Gestwicki,et al.  Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein Interactions , 2013, Chemical biology & drug design.

[22]  M. Selsted,et al.  Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in Mouse Models of Bacteremic Sepsis , 2012, PloS one.

[23]  N. Neamati,et al.  Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. , 2012, Journal of medicinal chemistry.

[24]  D. Craik,et al.  Structural characterization of the cyclic cystine ladder motif of θ-defensins. , 2012, Biochemistry.

[25]  D. Craik,et al.  Design, Synthesis, Structural and Functional Characterization of Novel Melanocortin Agonists Based on the Cyclotide Kalata B1* , 2012, The Journal of Biological Chemistry.

[26]  D. Craik.  Protein folding: Turbo-charged crosslinking. , 2012, Nature chemistry.

[27]  David J Craik,et al.  Therapeutic potential of conopeptides. , 2012, Future medicinal chemistry.

[28]  Jason E. Gestwicki,et al.  Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity , 2012, Expert Reviews in Molecular Medicine.

[29]  E. Montanya.  A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes , 2012, Expert opinion on pharmacotherapy.

[30]  K. Rosengren,et al.  Circular Proteins from Plants and Fungi* , 2012, The Journal of Biological Chemistry.

[31]  David J Craik,et al.  Thematic Minireview Series on Circular Proteins , 2012, The Journal of Biological Chemistry.

[32]  M. Selsted,et al.  θ-Defensins: Cyclic Peptides with Endless Potential* , 2012, The Journal of Biological Chemistry.

[33]  J. Camarero,et al.  Biological Synthesis of Circular Polypeptides* , 2012, The Journal of Biological Chemistry.

[34]  J. Tam,et al.  Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment. , 2012, Angewandte Chemie.

[35]  I. Vetter,et al.  Conus Venom Peptide Pharmacology , 2012, Pharmacological Reviews.

[36]  R. Lewis,et al.  Discovery and development of the χ-conopeptide class of analgesic peptides. , 2012, Toxicon : official journal of the International Society on Toxinology.

[37]  D. Craik,et al.  Discovery and applications of naturally occurring cyclic peptides. , 2012, Drug discovery today. Technologies.

[38]  Masa Cemazar,et al.  Cyclotides as a basis for drug design , 2012, Expert opinion on drug discovery.

[39]  Asher Mullard,et al.  2011 FDA drug approvals , 2012, Nature Reviews Drug Discovery.

[40]  J. Willmann,et al.  Pharmacokinetically Stabilized Cystine Knot Peptides That Bind Alpha-v-Beta-6 Integrin with Single-Digit Nanomolar Affinities for Detection of Pancreatic Cancer , 2011, Clinical Cancer Research.

[41]  Julie H. Campbell,et al.  Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. , 2011, Blood.

[42]  A. Lesner,et al.  Sunflower trypsin inhibitor 1 as a molecular scaffold for drug discovery. , 2011, Current pharmaceutical design.

[43]  J. Tanha,et al.  Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability , 2011, PloS one.

[44]  D. Craik,et al.  Chemical Synthesis of Naturally-Occurring Cyclic Mini-Proteins from Plants and Animals , 2011 .

[45]  D. Craik,et al.  Effects of cyclization on stability, structure, and activity of α-conotoxin RgIA at the α9α10 nicotinic acetylcholine receptor and GABA(B) receptor. , 2011, Journal of medicinal chemistry.

[46]  M. Wiranowska,et al.  Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma , 2011, Cancer Cell International.

[47]  Patrick S Daugherty,et al.  Protease-resistant peptide ligands from a knottin scaffold library. , 2011, ACS chemical biology.

[48]  A. Cole,et al.  Retrocyclins and their activity against HIV-1 , 2011, Cellular and Molecular Life Sciences.

[49]  Cyril F. Reboul,et al.  Mastering the Canonical Loop of Serine Protease Inhibitors: Enhancing Potency by Optimising the Internal Hydrogen Bond Network , 2011, PloS one.

[50]  J. Olson,et al.  Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. , 2011, Journal of medicinal chemistry.

[51]  M. Selsted,et al.  Rhesus macaque θ‐defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities , 2011, Journal of leukocyte biology.

[52]  A. Hallberg,et al.  Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP). , 2010, Journal of medicinal chemistry.

[53]  Paul Rösch,et al.  Cure and Curse: E. coli Heat-Stable Enterotoxin and Its Receptor Guanylyl Cyclase C , 2010, Toxins.

[54]  D. Craik,et al.  Conopeptide characterization and classifications: an analysis using ConoServer. , 2010, Toxicon : official journal of the International Society on Toxinology.

[55]  David J Craik,et al.  The engineering of an orally active conotoxin for the treatment of neuropathic pain. , 2010, Angewandte Chemie.

[56]  H. Kolmar,et al.  Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta. , 2010, Journal of molecular biology.

[57]  J. Frangioni,et al.  Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects , 2009, The Journal of Biological Chemistry.

[58]  D. Craik,et al.  Establishing regiocontrol of disulfide bond isomers of α‐conotoxin ImI via the synthesis of N‐to‐C cyclic analogs , 2009, Biopolymers.

[59]  C. Schroeder,et al.  chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. , 2009, Journal of medicinal chemistry.

[60]  J. Clements,et al.  Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4. , 2009, Chemistry & biology.

[61]  L. Poppe,et al.  Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure , 2009, The Journal of Biological Chemistry.

[62]  D. Craik,et al.  Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. , 2008, Journal of medicinal chemistry.

[63]  M. Selsted,et al.  Isolation, Synthesis, and Antimicrobial Activities of Naturally Occurring θ-Defensin Isoforms from Baboon Leukocytes , 2008, Infection and Immunity.

[64]  Edward W. Tate,et al.  Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides. , 2008, Organic & biomolecular chemistry.

[65]  Conan K. L. Wang,et al.  ConoServer, a database for conopeptide sequences and structures , 2008, Bioinform..

[66]  M. Selsted,et al.  Microbicidal Properties and Cytocidal Selectivity of Rhesus Macaque Theta Defensins , 2007, Antimicrobial Agents and Chemotherapy.

[67]  R. Dickson,et al.  Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1. , 2007, Journal of medicinal chemistry.

[68]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[69]  Nina M. Muñoz,et al.  Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.

[70]  A. Waring,et al.  Retrocyclins Kill Bacilli and Germinating Spores of Bacillus anthracis and Inactivate Anthrax Lethal Toxin* , 2006, Journal of Biological Chemistry.

[71]  Michelle L Colgrave,et al.  Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter. , 2006, Journal of medicinal chemistry.

[72]  Vasso Apostolopoulos,et al.  Round and round we go: cyclic peptides in disease. , 2006, Current medicinal chemistry.

[73]  David J. Craik,et al.  Seamless Proteins Tie Up Their Loose Ends , 2006, Science.

[74]  Jason P. Mulvenna,et al.  CyBase: a database of cyclic protein sequence and structure , 2005, Nucleic Acids Res..

[75]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[76]  A. Waring,et al.  The N‐terminus of Hepcidin is Essential for Its Interaction with Ferroportin: Structure‐Function Study , 2005, Blood.

[77]  Ian Paterson,et al.  The Renaissance of Natural Products as Drug Candidates , 2005, Science.

[78]  D. Sorriento,et al.  Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[79]  Norelle L Daly,et al.  Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[80]  A. Waring,et al.  Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins , 2005, Nature Immunology.

[81]  V. Hruby,et al.  Design of cyclic and other templates for potent and selective peptide α-MSH analogues , 2005 .

[82]  C. Chi,et al.  Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application. , 2005, Acta biochimica et biophysica Sinica.

[83]  D. Craik,et al.  Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1. , 2005, Biochemistry.

[84]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[85]  Christopher T. Walsh,et al.  Lessons from natural molecules , 2004, Nature.

[86]  K. Gustafson,et al.  Anti-HIV cyclotides. , 2004, Current protein & peptide science.

[87]  Horst Joachim Schirra,et al.  Sunflower trypsin inhibitor-1. , 2004, Current protein & peptide science.

[88]  Michelle L Colgrave,et al.  Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. , 2004, Biochemistry.

[89]  J. Stewart.  Bradykinin antagonists: discovery and development , 2004, Peptides.

[90]  L. Bohlin,et al.  Cytotoxic cyclotides from Viola tricolor. , 2004, Journal of natural products.

[91]  J. Ware,et al.  Therapeutic angiogenesis in cardiovascular disease , 2003, Nature Reviews Drug Discovery.

[92]  M. Matsuo,et al.  Angiogenic activity of osteopontin-derived peptide SVVYGLR. , 2003, Biochemical and biophysical research communications.

[93]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[94]  Joel A Swanson,et al.  Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.

[95]  Harald Sontheimer,et al.  Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2* , 2003, The Journal of Biological Chemistry.

[96]  C. Sevier,et al.  Formation and transfer of disulphide bonds in living cells , 2002, Nature Reviews Molecular Cell Biology.

[97]  V. Hruby.  Designing peptide receptor agonists and antagonists , 2002, Nature Reviews Drug Discovery.

[98]  H. Sontheimer,et al.  Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin , 2002, Glia.

[99]  A. Jaśkiewicz,et al.  Chemical synthesis and kinetic study of the smallest naturally occurring trypsin inhibitor SFTI-1 isolated from sunflower seeds and its analogues. , 2002, Biochemical and biophysical research communications.

[100]  O. Yang,et al.  Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[101]  Clement Waine,et al.  Biosynthesis and insecticidal properties of plant cyclotides: The cyclic knotted proteins from Oldenlandia affinis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[102]  D. Craik,et al.  Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. , 2001, Journal of molecular biology.

[103]  D. Craik,et al.  Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter , 2001, Nature Neuroscience.

[104]  F Sandberg,et al.  Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. , 2000, Journal of ethnopharmacology.

[105]  D. Craik,et al.  Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. , 1999, Journal of molecular biology.

[106]  S. Benkovic,et al.  Production of cyclic peptides and proteins in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Jun Yuan,et al.  A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. , 1999, Science.

[108]  J. Tam,et al.  An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[109]  S Luckett,et al.  High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. , 1999, Journal of molecular biology.

[110]  M. Khazaeli,et al.  Use of chlorotoxin for targeting of primary brain tumors. , 1998, Cancer research.

[111]  R. Luther,et al.  Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus. , 1998, Toxicon : official journal of the International Society on Toxinology.

[112]  R. Barrett,et al.  Increased potency of an erythropoietin peptide mimetic through covalent dimerization , 1997, Nature Biotechnology.

[113]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[114]  Ronald W. Barrett,et al.  Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.

[115]  A. Fahr.  Cyclosporin Clinical Pharmacokinetics , 1993, Clinical pharmacokinetics.

[116]  H. Kleinman,et al.  Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases , 1991, Cancer and Metastasis Reviews.

[117]  W R Gray,et al.  Peptide neurotoxins from fish-hunting cone snails. , 1985, Science.

[118]  D. Craik,et al.  Engineering cyclic peptide toxins. , 2012, Methods in enzymology.

[119]  J. W. Wong,et al.  Control of mature protein function by allosteric disulfide bonds. , 2011, Antioxidants & redox signaling.

[120]  D. Craik,et al.  Stabilization of α-conotoxin AuIB: influences of disulfide connectivity and backbone cyclization. , 2011, Antioxidants & redox signaling.

[121]  Mehdi Mobli,et al.  Venomics: a new paradigm for natural products-based drug discovery , 2010, Amino Acids.

[122]  M. Khrestchatisky,et al.  Synthetic therapeutic peptides: science and market. , 2010, Drug discovery today.

[123]  D. Craik,et al.  Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs. , 2010, Biopolymers.

[124]  Mercedes Martín-Martínez,et al.  Modulation of protein-protein interactions by stabilizing/mimicking protein secondary structure elements. , 2007, Current topics in medicinal chemistry.

[125]  B. Olivera,et al.  Conus venoms: a rich source of novel ion channel-targeted peptides. , 2004, Physiological reviews.